VELOCIMAB Trademark Information

Trademark by Regeneron Pharmaceuticals, Inc.

genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies

Classification Information

Use in Commerce Trademark - Applicant has provided proof of use of this mark in commerce to USPTO.

Primary Class: Class Details:
Class (042)
Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
First Use Anywhere:: 10/1/2007
First Use In Commerce: 10/1/2007
General Information
Word mark: VELOCIMAB
Status/Status Date:
REGISTERED AND RENEWED
1/7/2020
Serial Number: 77056928
Filing Date: 12/5/2006
Registration Number: 3718958
Registration Date: 12/1/2009
Goods and Services: genetic engineering services utilizing a collection of genetic technologies for the rapid production of human antibodies
Mark Description: NOT AVAILABLE
Type Of Mark: Service Mark
Published For Opposition Date: 7/3/2007
Last Applicant/Owner:
Regeneron Pharmaceuticals, Inc.
Tarrytown, NY 10591
Mark Drawing Code: Standard Character Mark
Design Search:
(NO DATA)
Register Type: Principal
Disclaimer: (NOT AVAILABLE)
Correspondent:
OHLANDT, GREELEY, RUGGIERO & PERLE, LLP
One Landmark Square
10TH FLOOR
STAMFORD, CT 06901
Current Status:
REGISTERED AND RENEWED
1/7/2020
Correspondent Search:
Terrence J. McAllister is a correspondent of VELOCIMAB trademark.
Current Overall Rating:
RatingRatingRatingRatingRating

(0 review)

As seen on